Parkinson's Disease

Effectiveness of tai chi for Parkinson's disease: A critical review
The objective of this review is to assess the effectiveness of tai chi as a treatment option for Parkinson's disease (PD). l
25 Victoria Park Road, Exeter, Devon EX2 4NT
Devon, UK
UK
Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really
It is essential to recognize and treat psychosis in Parkinson's disease for several reasons.

Gainesville, FL
USA
Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding
Psychosis in Parkinson's disease refers to a combination of hallucinations and delusions occurring with a clear sensorium and a chronic course.

Créteil, France
France
[Rotigotine in the treatment of Parkinson's disease. A study on a sample of 150 patients]
INTRODUCTION: Rotigotine is a non-ergot dopamine agonist that has become the first treatment for Parkinson's disease formulated as a transdermal release system.

Madrid, Spain
Spain
The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force contro
The persistent effects of unilateral deep brain stimulation (DBS) of the globus pallidus interna (GPi) or subthalamic nucleus (STN) on specific movement parameters produced by Parkinson's disease (PD) patients are poorly understood.

Cleveland, OH
USA
Recent advances in cell-based therapy for Parkinson disease
In this review, the authors discuss recent advances in the field of cell therapy for Parkinson disease (PD).

Belmont, MA 02478
USA
Placebo influences on dyskinesia in Parkinson's disease
Clinical features that are prognostic indicators of placebo response among dyskinetic Parkinson's disease patients were determined.

Chicago, IL
USA
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease deme
BACKGROUND AND AIM: Rivastigmine is now widely approved for the treatment of mild to moderately severe dementia in Parkinson's disease (PDD).

Marburg, Germany
Germany